Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma

Fig. 2

Validation of the novel immune checkpoint-based signature in patients with LUAD from GEO cohorts. A–G Kaplan–Meier curves of overall survival in the different GEO cohorts. H A meta-analysis of the prognostic value of the immune signature model when used to predict outcomes in the TCGA and GEO cohorts. The overall P-value (across all models) was determined from the meta-analysis

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us